{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:59:00Z","timestamp":1781344740444,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00428-025-04176-5","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T02:37:31Z","timestamp":1752633451000},"page":"1243-1251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential expression of PTEN, pAKT1, pRPS6, and mismatch repair proteins in pituitary neuroendocrine tumors"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-2828","authenticated-orcid":false,"given":"Mehmet Arda","family":"Inan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-0489","authenticated-orcid":false,"given":"Melike","family":"Urganci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-0903","authenticated-orcid":false,"given":"Berkay","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-6078","authenticated-orcid":false,"given":"Meric","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1804-2730","authenticated-orcid":false,"given":"Melih","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-7542","authenticated-orcid":false,"given":"Emrah","family":"Celtikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3316-3020","authenticated-orcid":false,"given":"Aylar","family":"Poyraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"1","key":"4176_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002.PubMedCentral","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37(1):123\u201334.e5. https:\/\/doi.org\/10.1016\/j.ccell.2019.11.002.PubMedCentral","journal-title":"Cancer Cell"},{"issue":"1","key":"4176_CR2","doi-asserted-by":"publisher","first-page":"e240070","DOI":"10.1530\/erc-24-0070.PubMedCentral","volume":"32","author":"MM Jentus","year":"2025","unstructured":"Jentus MM, Bakker L, Verstegen M et al (2025) Chromosomal alteration patterns in PitNETs: massive losses in aggressive tumors. Endocr Relat Cancer 32(1):e240070. https:\/\/doi.org\/10.1530\/erc-24-0070.PubMedCentral","journal-title":"Endocr Relat Cancer"},{"issue":"28","key":"4176_CR3","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.18632\/oncotarget.27660","volume":"11","author":"EY Xu","year":"2020","unstructured":"Xu EY, Vosburgh E, Wong C et al (2020) Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice. Oncotarget. 11(28):2718\u201339. https:\/\/doi.org\/10.18632\/oncotarget.27660","journal-title":"Oncotarget."},{"issue":"1","key":"4176_CR4","doi-asserted-by":"publisher","first-page":"167543","DOI":"10.1016\/j.bbadis.2024.167543","volume":"1871","author":"\u00c1 Flores-Mart\u00ednez","year":"2025","unstructured":"Flores-Mart\u00ednez \u00c1, Ramos-Herrero VD, Barroso A et al (2025) Conditional Pten inactivation in pituitary results in sex-specific prolactinoma formation. Biochim Biophys Acta Mol Basis Dis 1871(1):167543. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167543","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Pt 20","key":"4176_CR5","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(Pt 20):3589\u201394. https:\/\/doi.org\/10.1242\/jcs.051011","journal-title":"J Cell Sci"},{"issue":"5","key":"4176_CR6","first-page":"511","volume":"36","author":"M Bujko","year":"2015","unstructured":"Bujko M, Kober P, Zbijewska J et al (2015) Microsatellite instability analysis in pituitary adenomas. Neuro Endocrinol Lett 36(5):511\u20134","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"4176_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/bf02894277","volume":"19","author":"M Vaish","year":"2004","unstructured":"Vaish M, Kumar R, Mittal RD et al (2004) Evaluation of microsatellite instability in tumors of central nervous system: a pilot study. Indian J Clin Biochem: IJCB 19(2):156\u201362. https:\/\/doi.org\/10.1007\/bf02894277","journal-title":"Indian J Clin Biochem: IJCB"},{"issue":"7","key":"4176_CR8","first-page":"1417","volume":"12","author":"J Zhu","year":"1996","unstructured":"Zhu J, Guo SZ, Beggs AH et al (1996) Microsatellite instability analysis of primary human brain tumors. Oncogene 12(7):1417\u201323","journal-title":"Oncogene"},{"key":"4176_CR9","unstructured":"Board WCoTE (2022) Endocrine and neuroendocrine tumours. 10. PubMed Central"},{"issue":"8","key":"4176_CR10","first-page":"716","volume":"109","author":"KS McCarty Jr","year":"1985","unstructured":"McCarty KS Jr, Miller LS, Cox EB et al (1985) Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109(8):716\u201321","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"4176_CR11","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/erc-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an international pituitary pathology club proposal. Endocr Relat Cancer 24(4):C5-c8. https:\/\/doi.org\/10.1530\/erc-17-0004","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"4176_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","volume":"31","author":"O Mete","year":"2018","unstructured":"Mete O, Cintosun A, Pressman I et al (2018) Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol 31(6):900\u20139. https:\/\/doi.org\/10.1038\/s41379-018-0016-8","journal-title":"Mod Pathol"},{"issue":"1","key":"4176_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5144\/0256-4947.2024.55","volume":"44","author":"BF Alqeeq","year":"2024","unstructured":"Alqeeq BF, Ayyad M, Almadhoun WJ et al (2024) Sex-related differences in Cushing\u2019s disease: a systematic review and meta-analysis. Ann Saudi Med 44(1):55\u201365. https:\/\/doi.org\/10.5144\/0256-4947.2024.55","journal-title":"Ann Saudi Med"},{"issue":"2","key":"4176_CR14","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290.PubMedCentral","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33(2):101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290.PubMedCentral","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4176_CR15","doi-asserted-by":"publisher","first-page":"1338345","DOI":"10.3389\/fendo.2024.1338345","volume":"15","author":"L Dzialach","year":"2024","unstructured":"Dzialach L, Sobolewska J, Zak Z et al (2024) Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment. Front Endocrinol 15:1338345. https:\/\/doi.org\/10.3389\/fendo.2024.1338345","journal-title":"Front Endocrinol"},{"issue":"6","key":"4176_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/eje-14-0990","volume":"172","author":"E Delgrange","year":"2015","unstructured":"Delgrange E, Vasiljevic A, Wierinckx A et al (2015) Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. Eur J Endocrinol 172(6):791\u2013801. https:\/\/doi.org\/10.1530\/eje-14-0990","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"4176_CR17","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/jcp.26025","volume":"233","author":"PA Perez","year":"2018","unstructured":"Perez PA, Petiti JP, Picech F et al (2018) Estrogen receptor \u03b2 regulates the tumoral suppressor PTEN to modulate pituitary cell growth. J Cell Physiol 233(2):1402\u201313. https:\/\/doi.org\/10.1002\/jcp.26025","journal-title":"J Cell Physiol"},{"issue":"7","key":"4176_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jnen\/nlz040.PubMedCentral","volume":"78","author":"J Chen","year":"2019","unstructured":"Chen J, Schmidt RE, Dahiya S (2019) Pituitary adenoma in pediatric and adolescent populations. J Neuropathol Exp Neurol 78(7):626\u2013632. https:\/\/doi.org\/10.1093\/jnen\/nlz040.PubMedCentral","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"4176_CR19","first-page":"415","volume":"188","author":"C Taranger-Charpin","year":"2004","unstructured":"Taranger-Charpin C, Carpentier S, Dales JP et al (2004) Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia. Bull Acad Natl Med 188(3):415\u201327","journal-title":"Bull Acad Natl Med"},{"issue":"1","key":"4176_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/PGP.0b013e3182230d00","volume":"31","author":"K Garg","year":"2012","unstructured":"Garg K, Broaddus RR, Soslow RA et al (2012) Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible. Int J Gynecol Pathol 31(1):48\u201356. https:\/\/doi.org\/10.1097\/PGP.0b013e3182230d00","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"4176_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13046-022-02245-0.PubMedCentral","volume":"41","author":"J Guo","year":"2022","unstructured":"Guo J, Li C, Fang Q et al (2022) The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1. J Exp Clin Cancer Res 41(1):26. https:\/\/doi.org\/10.1186\/s13046-022-02245-0.PubMedCentral","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4176_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029.PubMedCentral","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S et al (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell 22(2):159\u2013168. https:\/\/doi.org\/10.1016\/j.molcel.2006.03.029.PubMedCentral","journal-title":"Mol Cell"},{"issue":"7","key":"4176_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/onc.2016.264.PubMedCentral","volume":"36","author":"R Chen","year":"2017","unstructured":"Chen R, Duan J, Li L et al (2017) mTOR promotes pituitary tumor development through activation of PTTG1. Oncogene 36(7):979\u2013988. https:\/\/doi.org\/10.1038\/onc.2016.264.PubMedCentral","journal-title":"Oncogene"},{"issue":"10","key":"4176_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/qjmed\/hcy133","volume":"111","author":"P Srichomkwun","year":"2018","unstructured":"Srichomkwun P, Houngngam N, Boonchaya-Anant P et al (2018) Cowden syndrome and pituitary tumours. QJM: Int J Med 111(10):735\u20136. https:\/\/doi.org\/10.1093\/qjmed\/hcy133","journal-title":"QJM: Int J Med"},{"key":"4176_CR25","doi-asserted-by":"publisher","first-page":"e934846","DOI":"10.12659\/ajcr.934846","volume":"23","author":"H Zhang","year":"2022","unstructured":"Zhang H, Li J, Lee M et al (2022) Pituitary carcinoma in a patient with Cowden syndrome. Am J Case Rep 23:e934846. https:\/\/doi.org\/10.12659\/ajcr.934846","journal-title":"Am J Case Rep"},{"issue":"10","key":"4176_CR26","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41431-020-0651-7.PubMedCentral","volume":"28","author":"M Tischkowitz","year":"2020","unstructured":"Tischkowitz M, Colas C, Pouwels S et al (2020) Cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet 28(10):1387\u20131393. https:\/\/doi.org\/10.1038\/s41431-020-0651-7.PubMedCentral","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"4176_CR27","doi-asserted-by":"publisher","first-page":"104080","DOI":"10.1016\/j.lpm.2021.104080.PubMedCentral","volume":"50","author":"LE Wildemberg","year":"2021","unstructured":"Wildemberg LE, Fialho C, Gadelha MR (2021) Prolactinomas. La Presse M\u00e9d 50(4):104080. https:\/\/doi.org\/10.1016\/j.lpm.2021.104080.PubMedCentral","journal-title":"La Presse M\u00e9d"},{"issue":"12","key":"4176_CR28","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2174\/1871530323666230511104045","volume":"23","author":"R Cozzi","year":"2023","unstructured":"Cozzi R, Simona Auriemma R, De Menis E et al (2023) Italian Guidelines for the Management of Prolactinomas. Endocr Metab Immune Disord Drug Targets 23(12):1459\u201379. https:\/\/doi.org\/10.2174\/1871530323666230511104045","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"4","key":"4176_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11102-023-01340-5","volume":"26","author":"AL Lin","year":"2023","unstructured":"Lin AL, Geer EB, Lala N et al (2023) The treatment of aggressive prolactinomas with everolimus. Pituitary 26(4):474\u201381. https:\/\/doi.org\/10.1007\/s11102-023-01340-5","journal-title":"Pituitary"},{"key":"4176_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019.PubMedCentral","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P (2022) Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol 85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.PubMedCentral","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4176_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/nan.12675.PubMedCentral","volume":"47","author":"RA Hickman","year":"2021","unstructured":"Hickman RA, Bruce JN, Otten M et al (2021) Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway. Neuropathol Appl Neurobiol 47(3):415\u2013427. https:\/\/doi.org\/10.1111\/nan.12675.PubMedCentral","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"4176_CR32","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.23015","volume":"61","author":"MC Olave","year":"2022","unstructured":"Olave MC, Graham RP (2022) Mismatch repair deficiency: the what, how and why it is important. Genes Chromosomes Cancer 61(6):314\u201321. https:\/\/doi.org\/10.1002\/gcc.23015","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04176-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04176-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04176-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:54:16Z","timestamp":1781344456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04176-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04176-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}